Fiduciary Trust CO Apellis Pharmaceuticals, Inc. Transaction History

Fiduciary Trust CO

$6.98 Billion
Q3 2024

A detailed history of Fiduciary Trust CO transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 236,066 shares of APLS stock, worth $7.82 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

236,066

Previous 240,286 1.76%

Holding current value

$7.82 Million

Previous $9.22 Million 26.14%

% of portfolio

0.1%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $121,704 - $173,653	-4,220 Reduced 1.76%	236,066 $6.81 Million
Q2 2024 Aug 14, 2024	SELL	$38.07 - $59.71 $26,649 - $41,797	-700 Reduced 0.29%	240,286 $9.22 Million
Q1 2024 May 13, 2024	SELL	$55.39 - $72.47 $89,787 - $117,473	-1,621 Reduced 0.67%	240,986 $14.2 Million
Q4 2023 Feb 12, 2024	SELL	$37.14 - $64.82 $839,364 - $1.46 Million	-22,600 Reduced 8.52%	242,607 $14.5 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $205,967 - $777,016	-8,709 Reduced 3.18%	265,207 $10.1 Million
Q2 2023 Aug 01, 2023	SELL	$76.68 - $93.31 $20.6 Million - $25 Million	-268,375 Reduced 49.49%	273,916 $25 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $461,241 - $662,903	-9,900 Reduced 1.79%	542,291 $35.8 Million
Q4 2022 Feb 13, 2023	SELL	$43.24 - $61.04 $380,512 - $537,152	-8,800 Reduced 1.57%	552,191 $28.6 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $171,654 - $267,146	-3,835 Reduced 0.68%	560,991 $38.3 Million
Q1 2022 May 12, 2022	SELL	$35.46 - $54.12 $531 - $811	-15 Reduced -0.0%	564,826 $28.7 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $1,075 - $1,720	-35 Reduced 0.01%	564,841 $26.7 Million
Q3 2021 Nov 12, 2021	BUY	$31.4 - $69.84 $29,076 - $64,671	926 Added 0.16%	564,876 $18.6 Million
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $61,350 - $97,350	-1,500 Reduced 0.27%	563,950 $35.6 Million
Q1 2021 May 19, 2021	SELL	$40.8 - $57.39 $310,936 - $437,369	-7,621 Reduced 1.33%	565,450 $24.3 Million
Q4 2020 Jan 26, 2021	BUY	$30.79 - $57.2 $76,359 - $141,856	2,480 Added 0.43%	573,071 $32.8 Million
Q3 2020 Nov 13, 2020	SELL	$25.89 - $33.65 $569,580 - $740,300	-22,000 Reduced 3.71%	570,591 $17.2 Million
Q2 2020 Aug 13, 2020	BUY	$24.8 - $38.49 $21,799 - $33,832	879 Added 0.15%	592,591 $19.4 Million
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $56,846 - $140,703	3,174 Added 0.54%	591,712 $15.9 Million
Q4 2019 Feb 04, 2020	SELL	$22.1 - $30.8 $2.59 Million - $3.62 Million	-117,385 Reduced 16.63%	588,538 $18 Million
Q3 2019 Nov 12, 2019	BUY	$24.09 - $32.18 $40,350 - $53,901	1,675 Added 0.24%	705,923 $17 Million
Q2 2019 Aug 14, 2019	SELL	$18.0 - $25.34 $23,400 - $32,942	-1,300 Reduced 0.18%	704,248 $17.8 Million
Q4 2018 Jan 29, 2019	BUY	$11.47 - $18.71 $8.09 Million - $13.2 Million	705,548 New	705,548 $9.31 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Account

Fiduciary Trust CO Apellis Pharmaceuticals, Inc. Transaction History